Paul Tudor Jones's TECH Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 943,287 shares of Bio-Techne Corporation (TECH) worth $66.64 M, representing 0.09% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 28 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in TECH, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 943,287 shares. Largest reduction occurred in Q1 2026, reducing 206,329 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +943,287 | New Buy | 943,287 | $70.65 |
| Q1 2026 | -206,329 | Sold Out | 0 | $0.00 |
| Q4 2025 | -35,687 | Reduce 14.75% | 206,329 | $58.81 |
| Q3 2025 | +242,016 | New Buy | 242,016 | $55.63 |
| Q2 2024 | -18,183 | Sold Out | 0 | $0.00 |
| Q1 2024 | +18,183 | New Buy | 18,183 | $70.39 |
| Q2 2023 | -164,262 | Sold Out | 0 | $0.00 |
| Q1 2023 | +85,574 | Add 108.75% | 164,262 | $0.07 |
| Q4 2022 | +548 | Add 0.70% | 78,688 | $0.08 |
| Q3 2022 | +45,408 | Add 138.73% | 78,140 | $71.00 |
| Q2 2022 | +32,732 | New Buy | 32,732 | $86.67 |
| Q3 2021 | -13,268 | Sold Out | 0 | $0.00 |
| Q2 2021 | +10,084 | Add 316.71% | 13,268 | $112.60 |
| Q1 2021 | -11,956 | Reduce 78.97% | 3,184 | $95.48 |
| Q4 2020 | -9,044 | Reduce 37.40% | 15,140 | $79.39 |
| Q3 2020 | +24,184 | New Buy | 24,184 | $61.94 |
| Q2 2020 | -20,912 | Sold Out | 0 | $0.00 |
| Q1 2020 | +13,516 | Add 182.75% | 20,912 | $47.39 |
| Q4 2019 | +7,396 | New Buy | 7,396 | $54.89 |
| Q3 2019 | -25,612 | Sold Out | 0 | $0.00 |
| Q2 2019 | +25,612 | New Buy | 25,612 | $52.12 |
| Q3 2016 | -30,800 | Sold Out | 0 | $0.00 |
| Q2 2016 | +16,800 | Add 120.00% | 30,800 | $28.18 |
| Q1 2016 | +14,000 | New Buy | 14,000 | $23.64 |
| Q2 2015 | -16,400 | Sold Out | 0 | $0.00 |
| Q1 2015 | -6,000 | Reduce 26.79% | 16,400 | $25.06 |
| Q4 2014 | -6,400 | Reduce 22.22% | 22,400 | $23.08 |
| Q3 2014 | +28,800 | New Buy | 28,800 | $23.40 |
Paul Tudor Jones's Bio-Techne Corporation Investment FAQs
Paul Tudor Jones first purchased Bio-Techne Corporation (TECH) in Q3 2014, acquiring 28,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Bio-Techne Corporation (TECH) for 28 quarters since Q3 2014.
Paul Tudor Jones's largest addition to Bio-Techne Corporation (TECH) was in Q2 2026, adding 943,287 shares worth $66.64 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 943,287 shares of Bio-Techne Corporation (TECH), valued at approximately $66.64 M.
As of the Q2 2026 filing, Bio-Techne Corporation (TECH) represents approximately 0.09% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Bio-Techne Corporation (TECH) was 943,287 shares, as reported at the end of Q2 2026.